食品科学

• 营养卫生 • 上一篇    下一篇

折伦诺对人乳腺癌细胞增殖作用及其类雌激素活性评价

钟赛意,刘寿春,秦小明,王维民,林华娟,谌素华   

  1. 1.广东海洋大学食品科技学院,广东 湛江 524005;2.北京市农林科学院 北京农业信息技术研究中心,北京 100097
  • 出版日期:2013-06-15 发布日期:2013-06-03

Effect of Zeranol on Proliferation of Human Breast Cancer Cells and Evaluation of Estrogenic Activity

ZHONG Sai-yi,LIU Shou-chun,QIN Xiao-ming,WANG Wei-min,LIN Hua-juan,CHEN Su-hua   

  1. 1. College of Food Science and Technology, Guangdong Ocean University, Zhanjiang 524005, China;2. Beijing Research Center for Information Technology in Agriculture, Beijing Academy of Agriculture and Forestry Sciences, Beijing 100097, China
  • Online:2013-06-15 Published:2013-06-03

摘要:

目的:研究折伦诺(Zeranol)对人乳腺癌细胞增殖的影响及评价其类雌激素活性。方法:采用体外细胞培养模型,以MTS/PMS比色法检测Zeranol对雌激素受体阳性乳腺癌细胞系MCF-7和雌激素受体阴性乳腺癌细胞系MDAMB-231的增殖作用,采用台盼蓝染色和血球计数板计数测定Zeranol作用下MCF-7增殖的细胞生长曲线,并以雌激素受体完全拮抗剂ICI182,780作为工具药物,以此评价Zeranol发挥类雌激素效应与雌激素受体的关系。结果:与对照组相比较,Zeranol(2~50nmol/L)能明显促进MCF-7细胞的增殖,而对MDA-MB-231没有显著影响,同时还发现Zeranol对MCF-7细胞增殖效应能够被雌激素受体拮抗剂ICI182,780完全阻断。结论:低剂量Zeranol能够促进人乳腺癌细胞的增殖,具有类雌激素活性,此作用可能是通过雌激素受体(ER)所介导。

关键词: 折伦诺, 人乳腺癌细胞, 增殖, 类雌激素, 雌激素受体

Abstract:

Objective: To explore the effect of zeranol on the proliferation of human breast cancer cells and its estrogenic
activity. Methods: in vitro cell culture model was employed and estrogen receptor-positive and estrogen receptor-negative
human breast cancer cells were exposed to different doses of Zeranol. The cell proliferation was tested by MTS/PMS assay
and the cell growth curve of MCF-7 was measured by trypan blue staining and hemocytometer counting. Moreover, the
estrogenic effect of zeranol and its correlation with estrogen receptors were evaluated using estrogen receptor antagonist
ICI 182,780 as a too1. Results: Zeranol (2-50 nmol/L) effectively induced the proliferation of MCF-7 cells, but showed no
effect on ER-negative MDA-MB-231 cells. Moreover, its effect on MCF-7 cell proliferation was completely blocked by ICI
182,780. Conclusion: Low dose of Zeranol can stimulate the growth of estrogen receptor-positive breast cancer cell and has
relatively potent estrogenic activity presumably via estrogen receptor α-mediated pathway.

Key words: Zeranol, human breast cancer cells, proliferation, estrogenic activity, estrogen receptor